文献速递痛风与晶体性关节病血管炎

动脉粥样硬化斑块中尿酸单钠结晶沉积患者的主要心血管事件

Major cardiovascular events in patients with cardiovascular monosodium urate deposits in atherosclerotic plaques.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

这项回顾性队列研究纳入189例临床疑似痛风患者,采用双能CT评估心血管动脉粥样硬化斑块尿酸单钠沉积,中位随访33个月,发现存在心血管尿酸单钠沉积者主要不良心脏事件发生率高于无沉积者(25.9% vs 12.5%,OR 2.4,P=0.018)。

要点

  • 心血管尿酸单钠沉积患者主要不良心脏事件发生率为25.9%,无沉积者为12.5%。
  • 心血管尿酸单钠沉积与主要不良心脏事件风险升高相关(OR 2.4,P=0.018)。
  • 心血管尿酸单钠沉积患者血清急性期反应物、尿酸水平及CT钙评分均升高。

核心结论

  • 首次证明双能CT证实的心血管尿酸单钠沉积患者主要不良心脏事件风险更高。
  • 心血管尿酸单钠沉积患者心脏事件发生率更高,可能有助于痛风患者风险分层,因经典心血管风险评分或实验室标志物未能正确识别。

研究设计与样本

  • 回顾性队列研究,纳入2012年6月1日至2019年12月5日期间因临床疑似痛风行患肢及胸部双能CT检查的患者。
  • 从病历中获取临床和实验室参数,评估已确立的心血管危险因素,通过病史回顾确定主要不良心脏事件,CT扫描后中位随访33个月(范围0-108个月)。
  • 共189例患者有完整数据集:痛风131例(69.3%)、高尿酸血症40例(21.2%)、对照18例(9.5%)。

主要发现

  • 心血管尿酸单钠沉积患者85/189例(45%),其血清急性期反应物、尿酸水平及CT钙评分较无沉积者升高。
  • 35例(18.5%)发生主要不良心脏事件,其中心血管尿酸单钠沉积组22/85例(25.9%),无沉积组13/104例(12.5%),OR 2.4,P=0.018。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the association of cardiovascular atherosclerotic plaque monosodium urate deposits with the occurrence of major cardiovascular events in gout and hyperuricemia patients. METHODS: This retrospective cohort study included patients with clinically suspicion of gout, who performed a dual energy computed tomography of the affected limb and thorax between 1 June 2012 and 5 December 2019. Clinical and laboratory parameters were retrieved from patients' charts. Established cardiovascular risk factors were evaluated. Medical history review identified the presence of major adverse cardiac events with a median follow-up time of 33 months (range 0-108 months) after the performed computed tomography scan. RESULTS: Full data sets were available for 189 patients: 131 (69.3%) gout patients, 40 (21.2%) hyperuricemia patients and 18 (9.5%) controls. Patients with cardiovascular monosodium urate deposits (n = 85/189, 45%) revealed increased serum acute phase reactants, uric acid levels and calcium scores in computed tomography compared with patients without cardiovascular monosodium urate deposits. Major adverse cardiac events were observed in 35 patients (18.5%) with a higher prevalence in those patients revealing cardiovascular monosodium urate deposits (n = 22/85, 25.9%) compared with those without cardiovascular monosodium urate deposits (n = 13/104, 12.5%, OR 2.4, P = 0.018). CONCLUSION: This is the first study demonstrating the higher hazard of major adverse cardiac events in patients with dual energy computed tomography-verified cardiovascular monosodium urate deposits. The higher prevalence of cardiac events in patients with cardiovascular monosodium urate deposits may facilitate risk stratification of gout patients, as classical cardiovascular risk scores or laboratory markers fail in their proper identification.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Held J, Schwabl C, Haschka D, et al. Major cardiovascular events in patients with cardiovascular monosodium urate deposits in atherosclerotic plaques. Rheumatology (Oxford). 2025. PMID: 38652590. doi:10.1093/rheumatology/keae240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。